Stock listing

Anbio Biotechnology

Selected listing: N3B · DUS · EUR · DE

Anbio Biotechnology (Dusseldorf:N3B), Health Technology. Latest release Mar 17, 2026: Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare…

N3B:DUSEURDEUpdated September 25, 2026

Ticker: Dusseldorf:N3B
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Dusseldorf
Currency: EUR

Latest news from Anbio Biotechnology

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

March 16, 2026

Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025

October 7, 2025

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System

August 7, 2025

Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions

May 14, 2025

Anbio Biotechnology Announces Closing of Initial Public Offering

February 20, 2025

All Anbio Biotechnology news →

Research Anbio Biotechnology

Anbio Biotechnology company profile

View the public company page for Anbio Biotechnology on 6ix.

Anbio Biotechnology news

Read company news and market updates connected to Anbio Biotechnology.

Anbio Biotechnology investor events

Find investor webinars, events, and replay context for Anbio Biotechnology.